NF2 and undifferentiated carcinoma: NF2, encoding for Merlin, a component of the Hippo pathway (179), is mutated, in up to approximately 10% of anaplastic carcinomas, but rarely in high grade non-anaplastic carcinomas (HGDTC and PDTC).